• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索长期使用苯二氮䓬类药物的个体在驾驶表现和神经认知方面差异的方法。

An explorative approach to understanding individual differences in driving performance and neurocognition in long-term benzodiazepine users.

机构信息

Department of Neuropsychology and Psychopharmacology, Maastricht University, Maastricht, The Netherlands.

Division Pharmacology, Utrecht University, Utrecht, The Netherlands.

出版信息

Hum Psychopharmacol. 2021 Jul;36(4):e2778. doi: 10.1002/hup.2778. Epub 2021 Feb 6.

DOI:10.1002/hup.2778
PMID:33547849
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8365705/
Abstract

OBJECTIVE

Previous research reported cognitive and psychomotor impairments in long-term users of benzodiazepine receptor agonists (BZRAs). This article explores the role of acute intoxication and clinical complaints.

METHODS

Neurocognitive and on-road driving performance of 19 long-term (≥6 months) regular (≥twice weekly) BZRA users with estimated plasma concentrations, based on self-reported use, exceeding the therapeutic threshold (C +), and 31 long-term regular BZRA users below (C -), was compared to that of 76 controls.

RESULTS

BZRA users performed worse on tasks of response speed, processing speed, and sustained attention. Age, but not C or self-reported clinical complaints, was a significant covariate. Road-tracking performance was explained by C only. The C  + group exhibited increased mean standard deviation of lateral position comparable to that at blood-alcohol concentrations of 0.5 g/L.

CONCLUSIONS

Functional impairments in long-term BZRA users are not attributable to self-reported clinical complaints or estimated BZRA concentrations, except for road-tracking, which was impaired in CBZRA + users. Limitations to address are the lack of assessment of objective clinical complaints, acute task related stress, and actual BZRA plasma concentrations. In conclusion, the results confirm previous findings that demonstrate inferior performance across several psychomotor and neurocognitive domains in long-term BZRA users.

摘要

目的

先前的研究报告称,苯二氮䓬受体激动剂(BZRA)的长期使用者存在认知和精神运动损伤。本文探讨了急性中毒和临床症状的作用。

方法

根据自我报告的使用情况,将估计的血浆浓度超过治疗阈值(C+)的 19 名长期(≥6 个月)常规(≥每周两次)BZRA 使用者和 31 名长期常规 BZRA 使用者(C-)的神经认知和道路驾驶表现与 76 名对照者进行了比较。

结果

BZRA 使用者在反应速度、处理速度和持续注意力任务上的表现较差。年龄是显著的协变量,但 C 或自我报告的临床症状不是。仅 C 可以解释道路跟踪性能。C+组的横向位置标准差增加,与血液酒精浓度为 0.5 g/L 时的情况相当。

结论

除了与 CBZRA+使用者相关的道路跟踪外,长期 BZRA 使用者的功能障碍与自我报告的临床症状或估计的 BZRA 浓度无关。需要解决的限制是缺乏对客观临床症状、急性任务相关压力和实际 BZRA 血浆浓度的评估。总之,这些结果证实了先前的研究发现,即长期 BZRA 使用者在多个精神运动和神经认知领域的表现均较差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c593/8365705/b11194a0ea70/HUP-36-e2778-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c593/8365705/e071975ab6b4/HUP-36-e2778-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c593/8365705/b11194a0ea70/HUP-36-e2778-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c593/8365705/e071975ab6b4/HUP-36-e2778-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c593/8365705/b11194a0ea70/HUP-36-e2778-g001.jpg

相似文献

1
An explorative approach to understanding individual differences in driving performance and neurocognition in long-term benzodiazepine users.探索长期使用苯二氮䓬类药物的个体在驾驶表现和神经认知方面差异的方法。
Hum Psychopharmacol. 2021 Jul;36(4):e2778. doi: 10.1002/hup.2778. Epub 2021 Feb 6.
2
Driving performance and neurocognitive skills of long-term users of benzodiazepine anxiolytics and hypnotics.苯二氮䓬类抗焦虑药和催眠药长期使用者的驾驶性能和神经认知技能。
Hum Psychopharmacol. 2019 Nov;34(6):e2715. doi: 10.1002/hup.2715.
3
Supporting safe and gradual reduction of long-term benzodiazepine receptor agonist use: Development of the SAFEGUARDING-BZRAs toolkit using a codesign approach.支持安全和逐步减少长期苯二氮䓬类受体激动剂使用:使用共同设计方法开发 SAFEGUARDING-BZRAs 工具包。
Health Expect. 2022 Aug;25(4):1904-1918. doi: 10.1111/hex.13547. Epub 2022 Jun 7.
4
Driving performance and neurocognitive skills of long-term users of sedating antidepressants.长期使用镇静类抗抑郁药者的驾驶表现和神经认知技能。
Hum Psychopharmacol. 2021 Jan;36(1):1-12. doi: 10.1002/hup.2762. Epub 2020 Oct 1.
5
'I just thought that it was such an impossible thing': A qualitative study of barriers and facilitators to discontinuing long-term use of benzodiazepine receptor agonists using the Theoretical Domains Framework.“我只是觉得这太不可能了”:使用理论领域框架对苯二氮䓬受体激动剂长期使用停药的障碍和促进因素的定性研究。
Health Expect. 2022 Feb;25(1):355-365. doi: 10.1111/hex.13392. Epub 2021 Dec 3.
6
Long-Term Use of Benzodiazepines and Benzodiazepine-Related Drugs: A Register-Based Danish Cohort Study on Determinants and Risk of Dose Escalation.长期使用苯二氮䓬类药物和苯二氮䓬类相关药物:基于丹麦登记处的队列研究,探讨剂量递增的决定因素和风险。
Am J Psychiatry. 2024 Mar 1;181(3):246-254. doi: 10.1176/appi.ajp.20230075. Epub 2023 Sep 20.
7
'We need more support and doctors that understand the process of tapering …': A content analysis of free-text responses to a questionnaire on discontinuing long-term benzodiazepine receptor agonist use.“我们需要更多支持,也需要更多理解停药过程的医生……”:一项对长期苯二氮䓬类受体激动剂停药问卷的自由文本回复的内容分析。
Health Expect. 2024 Feb;27(1):e13962. doi: 10.1111/hex.13962.
8
Driving performance of long-term users of sedating antidepressants and benzodiazepines.长期使用镇静型抗抑郁药和苯二氮䓬类药物者的驾驶表现。
Traffic Inj Prev. 2024;25(7):902-911. doi: 10.1080/15389588.2024.2358093. Epub 2024 Jul 12.
9
Real-world evidence on the use of benzodiazepine receptor agonists and the risk of venous thromboembolism.关于使用苯二氮䓬受体激动剂与静脉血栓栓塞风险的真实世界证据。
J Thromb Haemost. 2020 Nov;18(11):2878-2888. doi: 10.1111/jth.15033. Epub 2020 Aug 31.
10
Association of Benzodiazepine Receptor Agonist Use With Changes in Psoriasis Severity in Adult Population: A Population-Based Study.苯二氮䓬受体激动剂的使用与成年人群银屑病严重程度变化的关联:一项基于人群的研究。
Front Pharmacol. 2021 Jul 5;12:596375. doi: 10.3389/fphar.2021.596375. eCollection 2021.

引用本文的文献

1
A scoping review of motor vehicle operator performance assessments for benzodiazepine receptor agonists.苯二氮䓬受体激动剂机动车驾驶员性能评估的范围综述
Explor Res Clin Soc Pharm. 2024 Nov 9;16:100538. doi: 10.1016/j.rcsop.2024.100538. eCollection 2024 Dec.
2
Effects of solriamfetol on on-the-road driving in participants with narcolepsy: A randomised crossover trial.索里昂对发作性睡病患者道路驾驶的影响:一项随机交叉试验。
Hum Psychopharmacol. 2023 Jan;38(1):e2858. doi: 10.1002/hup.2858. Epub 2022 Nov 24.
3
Effects of solriamfetol on on-the-road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea.

本文引用的文献

1
Driving performance and neurocognitive skills of long-term users of benzodiazepine anxiolytics and hypnotics.苯二氮䓬类抗焦虑药和催眠药长期使用者的驾驶性能和神经认知技能。
Hum Psychopharmacol. 2019 Nov;34(6):e2715. doi: 10.1002/hup.2715.
2
Effectiveness and safety of long-term benzodiazepine use in anxiety disorders: a systematic review and meta-analysis.长期使用苯二氮䓬类药物治疗焦虑障碍的有效性和安全性:系统评价和荟萃分析。
Int Clin Psychopharmacol. 2019 Sep;34(5):211-221. doi: 10.1097/YIC.0000000000000276.
3
Factors Associated With Long-term Benzodiazepine Use Among Older Adults.
索里昂®对阻塞性睡眠呼吸暂停相关日间嗜睡患者道路驾驶表现的影响。
Hum Psychopharmacol. 2022 Nov;37(6):e2845. doi: 10.1002/hup.2845. Epub 2022 May 28.
4
Comparing objective wakefulness and vigilance tests to on-the-road driving performance in narcolepsy and idiopathic hypersomnia.比较嗜睡症和特发性嗜睡症患者客观清醒和警觉测试与道路驾驶表现。
J Sleep Res. 2022 Jun;31(3):e13518. doi: 10.1111/jsr.13518. Epub 2021 Nov 9.
与老年人长期使用苯二氮䓬类药物相关的因素。
JAMA Intern Med. 2018 Nov 1;178(11):1560-1562. doi: 10.1001/jamainternmed.2018.2413.
4
Impaired Cognitive Control of Emotional Conflict in Trait Anxiety: A Preliminary Study Based on Clinical and Non-Clinical Individuals.特质焦虑中情绪冲突的认知控制受损:一项基于临床和非临床个体的初步研究
Front Psychiatry. 2018 Apr 6;9:120. doi: 10.3389/fpsyt.2018.00120. eCollection 2018.
5
Comparing the effects of oxazepam and diazepam in actual highway driving and neurocognitive test performance: a validation study.比较奥沙西泮和地西泮在实际公路驾驶和神经认知测试表现中的效果:一项验证研究。
Psychopharmacology (Berl). 2018 Apr;235(4):1283-1294. doi: 10.1007/s00213-018-4844-5. Epub 2018 Mar 2.
6
DrugBank 5.0: a major update to the DrugBank database for 2018.DrugBank 5.0:2018 年 DrugBank 数据库的重大更新。
Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. doi: 10.1093/nar/gkx1037.
7
Driving Performance of Depressed Patients who are Untreated or Receive Long-Term Antidepressant (SSRI/SNRI) Treatment.未治疗或接受长期抗抑郁药(SSRI/SNRI)治疗的抑郁症患者的驾驶表现。
Pharmacopsychiatry. 2017 Sep;50(5):182-188. doi: 10.1055/s-0043-111600. Epub 2017 Jul 3.
8
Simultaneous Antidepressant and Benzodiazepine New Use and Subsequent Long-term Benzodiazepine Use in Adults With Depression, United States, 2001-2014.2001 - 2014年美国抑郁症成年患者中同时使用抗抑郁药和苯二氮䓬类药物的新用途及随后的长期苯二氮䓬类药物使用情况
JAMA Psychiatry. 2017 Jul 1;74(7):747-755. doi: 10.1001/jamapsychiatry.2017.1273.
9
Drugs and Driving Research in Medicinal Drug Development.药物与驾驶研究在药物研发中的应用。
Trends Pharmacol Sci. 2017 Apr;38(4):319-321. doi: 10.1016/j.tips.2017.01.006. Epub 2017 Mar 7.
10
A pooled analysis of on-the-road highway driving studies in actual traffic measuring standard deviation of lateral position (i.e., "weaving") while driving at a blood alcohol concentration of 0.5 g/L.一项在实际交通中进行的公路驾驶研究的汇总分析,测量血液酒精浓度为0.5 g/L时驾驶过程中横向位置的标准差(即“摆动”)。
Psychopharmacology (Berl). 2017 Mar;234(5):837-844. doi: 10.1007/s00213-016-4519-z. Epub 2017 Jan 9.